Enlivex Therapeutics Ltd.
(NASDAQ : ENLV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.60%474.361.0%$995.46m
DHRDanaher Corp. 0.48%224.420.7%$673.88m
BSXBoston Scientific Corp. 1.75%34.401.0%$567.89m
MDTMedtronic Plc 1.20%113.820.6%$533.10m
ABTAbbott Laboratories 0.32%107.870.8%$499.36m
BDXBecton, Dickinson & Co. 1.79%242.771.0%$449.38m
ISRGIntuitive Surgical, Inc. 2.85%780.342.3%$400.44m
DXCMDexCom, Inc. 0.99%348.037.8%$389.88m
ALGNAlign Technology, Inc. 2.10%521.726.4%$336.96m
BAXBaxter International, Inc. 2.20%78.001.8%$298.54m
SYKStryker Corp. 2.04%239.561.3%$288.34m
QDELQuidel Corp. -3.69%193.577.7%$233.02m
AAgilent Technologies, Inc. 1.43%115.201.6%$230.22m
EWEdwards Lifesciences Corp. 2.58%85.810.4%$223.58m
IDXXIDEXX Laboratories, Inc. -0.64%457.153.8%$200.27m

Company Profile

Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn's disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company is headquartered in Nes-Ziona, Israel.